# Schedules of Controlled Substances: Placement of Tianeptine in Schedule I

**Action Urgency Score:** 20/100

| Field | Value |
|---|---|
| Agency | Justice Department; Drug Enforcement Administration |
| Type | Proposed rule |
| Action | Notice of proposed rulemaking. |
| Published | 2026-07-08 |
| Comments close | 2026-08-07 |
| Significant | No |
| CFR parts | 21 CFR 1308 |
| Summary | The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on per |
| Document number | 2026-13821 |

## Why this score


Source: Federal Register API (Office of the Federal Register) (https://www.federalregister.gov/documents/2026/07/08/2026-13821/schedules-of-controlled-substances-placement-of-tianeptine-in-schedule-i). Last refreshed: 2026-11-04T21:40:49.974Z.
Data from the Federal Register API; the published Federal Register document is authoritative. Informational only, not legal advice.